Dr Jennifer Allie, AUD | |
111 Hundertmark Rd Ste 115n, Chaska, MN 55318-1584 | |
(952) 361-2450 | |
Not Available |
Full Name | Dr Jennifer Allie |
---|---|
Gender | Female |
Speciality | Audiologist |
Location | 111 Hundertmark Rd Ste 115n, Chaska, Minnesota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487829560 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | (Minnesota) | Secondary |
231H00000X | Audiologist | 8299 (Minnesota) | Primary |
Provider Name | Ridgeview Medical Center |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1528364429 PECOS PAC ID: 9234041997 Enrollment ID: O20031111000183 |
News Archive
Working with fruit flies, scientists at Johns Hopkins have discovered a protein required for two neighboring cells to fuse and become one "super cell."
A one-day online therapy session can help treat postpartum depression (PPD), says a study led by McMaster University scientists.
In a letter to the Editor published this Wednesday (31st May 2017), a group of Canadian researchers have disclosed how a sting of words coming from a notable doctor nearly 4 decades ago was the seed that led to a nationwide epidemic of misuse and abuse of opioid painkiller drugs such as Vicodin and OxyContin.
High doses of antioxidant nutritional supplements, such as vitamins C and E, can increase genetic abnormalities in cells, which may predispose supplement-takers to developing cancer, according to a new study from the Cedars-Sinai Heart Institute.
Cell therapy company jCyte is launching a phase 2b clinical trial to test the safety and efficacy of its developmental retinitis pigmentosa (RP) treatment, jCell.
› Verified 6 days ago
Provider Name | On Site Hearing Services Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1811029028 PECOS PAC ID: 4082661558 Enrollment ID: O20050406000837 |
News Archive
Working with fruit flies, scientists at Johns Hopkins have discovered a protein required for two neighboring cells to fuse and become one "super cell."
A one-day online therapy session can help treat postpartum depression (PPD), says a study led by McMaster University scientists.
In a letter to the Editor published this Wednesday (31st May 2017), a group of Canadian researchers have disclosed how a sting of words coming from a notable doctor nearly 4 decades ago was the seed that led to a nationwide epidemic of misuse and abuse of opioid painkiller drugs such as Vicodin and OxyContin.
High doses of antioxidant nutritional supplements, such as vitamins C and E, can increase genetic abnormalities in cells, which may predispose supplement-takers to developing cancer, according to a new study from the Cedars-Sinai Heart Institute.
Cell therapy company jCyte is launching a phase 2b clinical trial to test the safety and efficacy of its developmental retinitis pigmentosa (RP) treatment, jCell.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jennifer Allie, AUD 500 S Maple St, Waconia, MN 55387-1791 Ph: (952) 442-2191 | Dr Jennifer Allie, AUD 111 Hundertmark Rd Ste 115n, Chaska, MN 55318-1584 Ph: (952) 361-2450 |
News Archive
Working with fruit flies, scientists at Johns Hopkins have discovered a protein required for two neighboring cells to fuse and become one "super cell."
A one-day online therapy session can help treat postpartum depression (PPD), says a study led by McMaster University scientists.
In a letter to the Editor published this Wednesday (31st May 2017), a group of Canadian researchers have disclosed how a sting of words coming from a notable doctor nearly 4 decades ago was the seed that led to a nationwide epidemic of misuse and abuse of opioid painkiller drugs such as Vicodin and OxyContin.
High doses of antioxidant nutritional supplements, such as vitamins C and E, can increase genetic abnormalities in cells, which may predispose supplement-takers to developing cancer, according to a new study from the Cedars-Sinai Heart Institute.
Cell therapy company jCyte is launching a phase 2b clinical trial to test the safety and efficacy of its developmental retinitis pigmentosa (RP) treatment, jCell.
› Verified 6 days ago